Dr Reddys Laboratories (RDY) Net Margin (2012 - 2026)

Dr Reddys Laboratories' Net Margin history runs 15 years deep, the most recent figure standing at 16.32% for Q1 2026.

• In Q1 2026, Net Margin fell 242.0% year-over-year to 16.32%; the TTM figure through Mar 2026 stood at 11.69% (down 567.0% YoY), while the FY2026 annual figure was 12.74%, down 466.0% from the prior year.
• Net Margin was 16.32% for Q1 2026 at Dr Reddys Laboratories, up from 13.86% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 22.78% in Q1 2022 to a low of 0.0% in Q3 2022.
• Historically, Net Margin has averaged 17.02% across 5 years, with a median of 17.86% in 2024.
• The sharpest annual moves came in 2022 and 2023: Net Margin sank 1327 bps in 2022, then jumped 2151 bps in 2023.
• A 5-year view of Net Margin shows it stood at 15.23% in 2022, then rose by 25 bps to 19.11% in 2023, then retreated by 12 bps to 16.91% in 2024, then slipped by 18 bps to 13.86% in 2025, then advanced by 18 bps to 16.32% in 2026.
• The last three Net Margin figures came in at 16.32% (Q1 2026), 13.86% (Q4 2025), and 16.59% (Q2 2025), per Business Quant data.